Stereotactic irradiation of the resection cavity after surgical resection of brain metastases – when is the right timing?

References

• Sul J, Posner JB. Brain metastases: epidemiology and pathophysiology. Cancer Treat Res. 2007;136:1–21.
   PubMedGoogle Scholar
• Kocher M, Wittig A, Piroth MD, et al. Stereotactic radiosurgery for treatment of brain metastases. A report of the DEGRO Working Group on Stereotactic Radiotherapy. Strahlenther Onkol. 2014;190:521–532.
   PubMed Web of Science ®Google Scholar
• Patchell RA, Tibbs PA, Regine WF, et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA. 1998;280:1485–1489.
   PubMed Web of Science ®Google Scholar
• Brown PD, Ballman KV, Cerhan JH, et al. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial. Lancet Oncol. 2017;18:1049–1060.
   PubMed Web of Science ®Google Scholar
• Mahajan A, Ahmed S, McAleer MF, et al. Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial. Lancet Oncol. 2017;18:1040.
   PubMed Web of Science ®Google Scholar
• Steinmann D, Maertens B, Janssen S, et al. Hypofractionated stereotactic radiotherapy (hfSRT) after tumour resection of a single brain metastasis: report of a single-centre individualized treatment approach. J Cancer Res Clin Oncol. 2012;138:1523–1529.
   PubMed Web of Science ®Google Scholar
• Azizi AA, Paur S, Kaider A, et al. Beeinflusst die Zeitspanne zwischen Tumorresektion und Strahlentherapie das Überleben bei Kindern mit hochgradigen Gliomen? Strahlenther Onkol. 2018;194:552–559.
   PubMed Web of Science ®Google Scholar
• Seidlitz A, Siepmann T, Löck S, et al. Impact of waiting time after surgery and overall time of postoperative radiochemotherapy on treatment outcome in glioblastoma multiforme. Radiat Oncol. 2015;10:172.
   PubMed Web of Science ®Google Scholar
• Adeberg S, Bostel T, Harrabi S, et al. Impact of delays in initiating postoperative chemoradiation while determining the MGMT promoter-methylation statuses of patients with primary glioblastoma. BMC Cancer. 2015;15:558.
   PubMed Web of Science ®Google Scholar
• Blumenthal DT, Won M, Mehta MP, et al. Short delay in initiation of radiotherapy may not affect outcome of patients with glioblastoma: a secondary analysis from the radiation therapy oncology group database. J Clin Oncol. 2009;27:733–739.
   PubMed Web of Science ®Google Scholar
• Tam M, Wu SP, Gerber NK, et al. The impact of adjuvant chemoradiotherapy timing on survival of head and neck cancers. Laryngoscope. 2018;128:2326–2332.
   PubMed Web of Science ®Google Scholar
• Tribius S, Donner J, Pazdyka H, et al. Survival and overall treatment time after postoperative radio(chemo)therapy in patients with head and neck cancer. Head Neck. 2016;38:1058–1065.
   PubMed Web of Science ®Google Scholar
• Fujiwara RJT, Judson BL, Yarbrough WG, et al. Treatment delays in oral cavity squamous cell carcinoma and association with survival. Head Neck. 2017;39:639–646.
   PubMed Web of Science ®Google Scholar
• Kim K, Chie EK, Han W, et al. Impact of delayed radiotherapy on local control in node-negative breast cancer patients treated with breast-conserving surgery and adjuvant radiotherapy without chemotherapy. Tumori. 2011;97:341–344.
   PubMed Web of Science ®Google Scholar
• Vujovic O, Cherian A, Yu E, et al. The effect of timing of radiotherapy after breast-conserving surgery in patients with positive or close resection margins, young age, and node-negative disease, with long term follow-up. Int J Radiat Oncol Biol Phys. 2006;66:687–690.
   PubMed Web of Science ®Google Scholar
• Peker S, Abacioglu U, Sun I, et al. Irradiation after surgically induced brain injury in the rat: timing in relation to severity of radiation damage. J Neurooncol. 2004;70:17–21.
   PubMed Web of Science ®Google Scholar
• Gaspar L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys. 1997;37:745–751.
   PubMed Web of Science ®Google Scholar
• Scharl S, Kirstein A, Kessel KA, et al. Volumenveränderungen der Resektionshöhlen nach Operation von Hirnmetastasen – Konsequenzen für die stereotaktische Strahlentherapie. Strahlenther Onkol. 2019;195:207–217.
   PubMed Web of Science ®Google Scholar
• Atalar B, Choi CYH, Harsh GR, et al. Cavity volume dynamics after resection of brain metastases and timing of postresection cavity stereotactic radiosurgery. Neurosurgery. 2013;72:180–185; discussion 185.
   PubMed Web of Science ®Google Scholar
• Moraes FY, Winter J, Atenafu EG, et al. Outcomes following SRS for small- to medium-sized brain metastases are exceptionally dependent upon tumor size and prescribed dose. Neuro-Oncology. 2018;21:242–251.
   Web of Science ®Google Scholar
• Wiggenraad R, Verbeek-de Kanter A, Kal HB, et al. Dose-effect relation in stereotactic radiotherapy for brain metastases. A systematic review. Radiother Oncol. 2011;98:292–297.
   PubMed Web of Science ®Google Scholar
• Horsman MR, Overgaard J. The impact of hypoxia and its modification of the outcome of radiotherapy. J Radiat Res. 2016;57(Suppl 1):i90–i98.
   PubMed Web of Science ®Google Scholar
• Krieg SM, Picht T, Sollmann N, et al. Resection of motor eloquent metastases aided by preoperative nTMS-based motor maps-comparison of two observational cohorts. Front Oncol. 2016;6:261.
   PubMed Web of Science ®Google Scholar
• Krieg SM, Schäffner M, Shiban E, et al. Reliability of intraoperative neurophysiological monitoring using motor evoked potentials during resection of metastases in motor-eloquent brain regions: clinical article. J Neurosurg. 2013;118:1269–1278.
   PubMed Web of Science ®Google Scholar